First-in-human study of the biodistribution and pharmacokinetics of ⁸⁹Zr-CX-072, a novel immunoPET tracer based on an anti-PD-L1 probody

Kist de Ruijter L, Hooiveld-Noeken JS, Giesen D, et al. [published online ahead of print, 2021 Jul 12]. Clin Cancer Res. 2021;clincanres.0453.2021. doi:10.1158/1078-0432.CCR-21-0453